August 20, 2014

Excedrin relaunched in the United States in 2013 and is doing well. The brand generated $130 million between its Excedrin tablets and Excedrin Migraine tablets for the 52 weeks ended June 15 across total U.S. multi-outlets, according to IRI.

July 21, 2014

Teva Pharmaceutical Industries on Monday announced that its acquistion of Labrys has been completed. The acquisition brings to Teva LBR-101, which is currently in phase-2b clinical trials for prevention of chronic and episodic migraines.

June 3, 2014

Teva Pharmaceutical and Labrys Biologics, a privately-held development stage biotechnology company focused on treatments for chronic migraine and episodic migraine, on Tuesday announced that Teva has entered into a definitive agreement to acquire Labrys in a deal for $200 million in upfront payment in cash at closing as well as up to $625 million in contingent payments upon achievement of certain pre-launch milestones.

April 24, 2014

Endo International announced that its affiliates have acquired rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use from Zogenix.

April 23, 2014

Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

March 31, 2014

The Food and Drug Administration on Friday approved Topamax (topiramate) for prevention of migraine headaches in adolescents ages 12 years to 17 years.

March 25, 2014

VR1 on Tuesday announced the availability of Ausanil, a new non-prescription homeopathic nasal spray formulated to provide rapid pain relief from severe headaches and migraines with no reported systemic side effects or adverse drug-drug interactions.

February 26, 2014

Dr. Reddy's Labs announced that it has launched Sumatriptan Injection USP, Autoinjector System 6-mg/0.5-mL, a generic version of Imitrex STATdose Pen (sumatriptan succinate) 6-mg/0.5-mL.

January 21, 2014

Teva Pharmaceutical announced that it has entered into a definitive agreement under which Teva will acquire NuPathe for $3.65 per share in cash.

December 16, 2013

Endo Health Solutions will acquire the maker of a patch used to treat migraines that received Food and Drug Administration approval at the beginning of this year.

October 24, 2013

GelStat Corp. on Wednesday announced that it has closed the acquisition of CBD Life Sciences.

May 21, 2013

Impax Labs has launched an authorized generic drug for migraine headaches under a partnership with AstraZeneca, Impax said.

May 15, 2013

The Food and Drug Administration has approved a generic migraine drug made by Mylan, the company said Wednesday.

May 6, 2013

Pregnant women should not use migraine-prevention medications containing valproate sodium due to a higher risk of decreased IQ scores in children, the Food and Drug Administration warned.

March 8, 2013

With private label across analgesics up an estimated 11.3% to $1.7 billion, retailers are going to need to make some tough decisions as two internal analgesic powerhouses — McNeil's Tylenol and Novartis' Excedrin — make their way back onto market after respective recalls.

February 5, 2013

GelStat Corporation announced that it has retained List Services Corporation to manage all branding and marketing efforts for GelStat and its products, GelStat Migraine and GelStat Sleep.

January 3, 2013

Par Pharmaceutical Cos. has started shipping two formulations of a generic drug for treating migraines, the company said.

November 27, 2012

Akeso Health Sciences on Tuesday announced the availability of MigreLief Triple Therapy with Puracol, a nonprescription, comprehensive supplement formulated to maintain normal cerebrovascular function by addressing the underlying nutritional deficiencies and imbalances common to many migraine sufferers.

November 14, 2012

Novartis Consumer Health on Wednesday announced the development of a convenient migraine trigger tracking tool, My Migraine Triggers App, with a neurologist.

September 24, 2012

Prestige Brands on Monday announced the launch of Goody's in a caplet format.

September 4, 2012

Bayer HealthCare's Consumer Care Division on Tuesday introduced Bayer Migraine Formula, an over-the-counter medication designed to relieve migraine pain and accompanying symptoms like nausea, phonophobia (sound sensitivity) and photophobia (light sensitivity) through a formulation of aspirin, acetaminophen and caffeine.

May 18, 2012

Solantic, an operator of urgent care centers in Florida, is changing its name to CareSpot Express Healthcare to represent a new brand and new vision for the company.

February 1, 2012

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

January 25, 2012

The National Advertising Review Board on Tuesday recommended that Novartis Consumer Health discontinue advertising claims that the company’s Excedrin Extra Strength product starts relieving headache pain faster than Advil.